Literature DB >> 2535981

T-cell populations in liver and renal transplant recipients with infectious esophagitis.

D E Brouillette1, J Alexander, Y K Yoo, M C Chien, R E Tarter, J Gavaler, D H Van Thiel.   

Abstract

Individuals undergoing hepatic and renal transplants are susceptible to infections of the gastrointestinal tract, particularly the esophagus. The most common responsible agents are Candida and herpes simplex virus (HSV) with cytomegalovirus (CMV), Aspergillus, and other agents being regarded as unusual pathogens even in this unique population. Altered T-cell populations have been associated with CMV colitis in healthy homosexuals and in individuals with the acquired immunodeficiency syndrome (AIDS). Similarly, individuals with Epstein-Barr virus infections have altered T-cell populations. Whether these infections alter T-cell populations in infected individuals or the abnormalities in T-cell subpopulations occur first and enhance the likelihood of an infection in susceptible populations is as yet unknown. In this study peripheral blood T-cell populations in individuals before (19 patients) and after (47 patients) liver transplantation and after receiving a renal allograft (21 patients) were compared. Those individual having any symptoms related to esophageal disease underwent upper gastrointestinal endoscopy combined with mucosal biopsies, brushings, and cultures and were subdivided into those with and without infectious esophagitis. CMV esophagitis was found to be associated with an arithmetically decreased T-cell helper/suppressor (H/S) ratio principally due to an increase in the suppressor cell number. Such a reduction in the TH/S ratio and in the number of circulating suppressor cells was not found in esophagitis due to either HSV or Candida and was unrelated to the serum cyclosporine level or prednisone dosage prescribed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535981     DOI: 10.1007/bf01536160

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Tuberculosis of the esophagus.

Authors:  Y Ito; S Kobayashi; T Kasugai
Journal:  Am J Gastroenterol       Date:  1976-05       Impact factor: 10.864

2.  Candida infection of the gastrointestinal tract.

Authors:  P Eras; M J Goldstein; P Sherlock
Journal:  Medicine (Baltimore)       Date:  1972-09       Impact factor: 1.889

3.  Herpes esophagitis in an otherwise healthy patient.

Authors:  L DeGaeta; M S Levine; G E Guglielmi; E C Raffensperger; I Laufer
Journal:  AJR Am J Roentgenol       Date:  1985-06       Impact factor: 3.959

4.  Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men.

Authors:  W L Drew; J Mills; J Lèvy; J Dylewski; C Casavant; A J Ammann; H Brodie; T Merigan
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391

5.  Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases.

Authors:  B Dworkin; G P Wormser; W S Rosenthal; S K Heier; M Braunstein; L Weiss; R Jankowski; D Levy; S Weiselberg
Journal:  Am J Gastroenterol       Date:  1985-10       Impact factor: 10.864

6.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

7.  Duodenal mucosal T cell subpopulation and bacterial cultures in acquired immune deficiency syndrome.

Authors:  M Budhraja; H Levendoglu; F Kocka; M Mangkornkanok; R Sherer
Journal:  Am J Gastroenterol       Date:  1987-05       Impact factor: 10.864

Review 8.  Candida esophagitis.

Authors:  R Mathieson; S K Dutta
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

9.  Esophagitis in the immunocompromised host: role of esophagoscopy in diagnosis.

Authors:  R R Wheeler; J E Peacock; J M Cruz; J E Richter
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

10.  Alterations of T-cell subsets in primary biliary cirrhosis.

Authors:  A K Bhan; J L Dienstag; J R Wands; S F Schlossman; E L Reinherz
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.